首页> 美国卫生研究院文献>The Canadian Journal of Infectious Diseases Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie M dicale >The challenges facing Canadian trialists in an increasingly competitive global market: What can be done to remain competitive?
【2h】

The challenges facing Canadian trialists in an increasingly competitive global market: What can be done to remain competitive?

机译:加拿大审判员在竞争日益激烈的全球市场中面临的挑战:如何保持竞争力?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Globally, the pharmaceutical industry is condensing into fewer, larger international corporations. This has occurred with the vaccine industry in Canada, where two domestic producers have been absorbed by international companies. This changes the relationship between Canadian vaccine researchers and corporate head office research directors, who carefully assign prelicensure studies to potential market countries around the globe. To succeed in attracting prelicensure vaccine studies, Canadian researchers need to be outstanding in quality, reliability and efficiency. The present article highlights strategies to help researchers remain internationally competitive for industry-sponsored pharmaceutical studies.
机译:在全球范围内,制药行业正在凝结为越来越少的大型国际公司。这在加拿大的疫苗行业中已经发生过,加拿大的两家国内生产商已被国际公司吸收。这改变了加拿大疫苗研究人员与公司总部研究主管之间的关系,后者仔细地将预许可研究分配给全球潜在的市场国家。为了成功吸引准许可疫苗研究,加拿大研究人员需要在质量,可靠性和效率方面出类拔萃。本文重点介绍了有助于研究人员在行业资助的药物研究方面保持国际竞争力的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号